Results 91 to 100 of about 30,750 (313)
Indian Journal of Critical Care Medicine, 2015 In this issue, the article “Candida glabrata candidemia: An emerging threat in critically ill patients” demands discussion on this topic as C. glabrata candidemia is difficult to manage and the patients have high mortality. Clinicians, epidemiologists, microbiologists, and basic scientists across the world are working on the epidemiology, pathogenesis,
openaire +2 more sources
Transplant Infectious Disease, EarlyView.ABSTRACT Introduction Studies evaluating the incidence of infections after belatacept as a substitute for calcineurin inhibitors (CNI) or antimetabolite in kidney transplant (KT) yielded conflicting results. We compared infectious outcomes after belatacept‐use to no belatacept‐use in KT recipients.
Hareesh Singam +5 more
wiley +1 more source
BMC Infectious Diseases, 2017 Background Candidemia is the worldwide life-threaten disease, especially in cancer patients. This study was aimed to identify and evaluate the risk factors of candidemia in cancer patients, which will prompt the improvement on current therapeutic ...
Ding Li +5 more
doaj +1 more source
Epidemiology of invasive candidiasis in a surgical intensive care unit: an observational study [PDF]
, 2015 Background: Invasive candidiasis (IC) is a frequent and life-threatening infection in critically ill patients. The aim of this study was to evaluate the epidemiology of IC and the antifungal susceptibility of etiological agents in patients admitted to ...
Ana Izquierdo +34 more
core +1 more source
Current Fungal Infection Reports, 2013 Patients with invasive fungal infections still have high morbidity and mortality despite an increasing number of antifungals and other therapies. Because of this problem, an accurate and rapid diagnosis is mandatory in order to improve clinical outcome in these patients. In this paper we review the tools for the diagnosis of candidemia, including blood
Vitale, Roxana Gabriela, Nucci, Marcio
openaire +2 more sources
Morbidity and mortality weekly report. Surveillance summaries, 2019 Problem/Condition Candidemia is a bloodstream infection (BSI) caused by yeasts in the genus Candida. Candidemia is one of the most common health care–associated BSIs in the United States, with all-cause in-hospital mortality of up to 30%.
Mitsuru Toda +12 more
semanticscholar +1 more source
Imidazolium‐Based Ionic Liquids as Antifungal and Antibiofilm Agents Against Candida tropicalis
ChemistrySelect, Volume 11, Issue 4, 28 January 2026.Candida sp. biofilms, particularly those formed on catheters, represent a major clinical challenge. This study evaluates ionic liquids using an experimental biofilm model, demonstrating significant antifungal activity and biofilm disruption, supporting their potential application as alternative strategies for device‐associated infection control ...
Giovanna de Jesus Agostinetto +4 more
wiley +1 more source
Economic Evaluation of Voriconazole for the Treatment of Candidemia in Canadian Adults
Canadian Journal of Infectious Diseases and Medical Microbiology, 2008 BACKGROUND: Candidemia is a common cause of nosocomial bloodstream infection. When selecting therapeutic treatments for candidemia, cost-effectiveness is an important consideration.
Coleman Rotstein +8 more
doaj +1 more source
Hsp90 governs dispersion and drug resistance of fungal biofilms [PDF]
, 2011 Fungal biofilms are a major cause of human mortality and are recalcitrant to most treatments due to intrinsic drug resistance. These complex communities of multiple cell types form on indwelling medical devices and their eradication often requires ...
A Lupetti +69 more
core +4 more sources
Japanese journal of infectious diseases (Print), 2022 Candidemia is an important clinical condition that prolongs the period of hospitalization and increases morbidity, mortality, and hospital costs. In this retrospective study, we aimed to evaluate the epidemiological and microbiological characteristics of
S. Aydın +8 more
semanticscholar +1 more source